165 related articles for article (PubMed ID: 15668958)
1. Growth-associated protein-43 is degraded via the ubiquitin-proteasome system.
De Moliner KL; Wolfson ML; Perrone Bizzozero N; Adamo AM
J Neurosci Res; 2005 Mar; 79(5):652-60. PubMed ID: 15668958
[TBL] [Abstract][Full Text] [Related]
2. Glutamate stimulates glutamate receptor interacting protein 1 degradation by ubiquitin-proteasome system to regulate surface expression of GluR2.
Guo L; Wang Y
Neuroscience; 2007 Mar; 145(1):100-9. PubMed ID: 17207582
[TBL] [Abstract][Full Text] [Related]
3. Proteasome inhibition by lactacystin in primary neuronal cells induces both potentially neuroprotective and pro-apoptotic transcriptional responses: a microarray analysis.
Yew EH; Cheung NS; Choy MS; Qi RZ; Lee AY; Peng ZF; Melendez AJ; Manikandan J; Koay ES; Chiu LL; Ng WL; Whiteman M; Kandiah J; Halliwell B
J Neurochem; 2005 Aug; 94(4):943-56. PubMed ID: 15992382
[TBL] [Abstract][Full Text] [Related]
4. cAMP-dependent protein kinase regulates ubiquitin-proteasome-mediated degradation and subcellular localization of the nuclear receptor coactivator GRIP1.
Hoang T; Fenne IS; Cook C; Børud B; Bakke M; Lien EA; Mellgren G
J Biol Chem; 2004 Nov; 279(47):49120-30. PubMed ID: 15347661
[TBL] [Abstract][Full Text] [Related]
5. NAC1 regulates the recruitment of the proteasome complex into dendritic spines.
Shen H; Korutla L; Champtiaux N; Toda S; LaLumiere R; Vallone J; Klugmann M; Blendy JA; Mackler SA; Kalivas PW
J Neurosci; 2007 Aug; 27(33):8903-13. PubMed ID: 17699672
[TBL] [Abstract][Full Text] [Related]
6. Dose-dependent inhibition of proteasome activity by a mutant ubiquitin associated with neurodegenerative disease.
van Tijn P; de Vrij FM; Schuurman KG; Dantuma NP; Fischer DF; van Leeuwen FW; Hol EM
J Cell Sci; 2007 May; 120(Pt 9):1615-23. PubMed ID: 17405812
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitin-proteasome pathway mediates degradation of APH-1.
He G; Qing H; Cai F; Kwok C; Xu H; Yu G; Bernstein A; Song W
J Neurochem; 2006 Dec; 99(5):1403-12. PubMed ID: 17059559
[TBL] [Abstract][Full Text] [Related]
8. Early degradation of paternal mitochondria in domestic pig (Sus scrofa) is prevented by selective proteasomal inhibitors lactacystin and MG132.
Sutovsky P; McCauley TC; Sutovsky M; Day BN
Biol Reprod; 2003 May; 68(5):1793-800. PubMed ID: 12606393
[TBL] [Abstract][Full Text] [Related]
9. Degradation of trafficking-defective long QT syndrome type II mutant channels by the ubiquitin-proteasome pathway.
Gong Q; Keeney DR; Molinari M; Zhou Z
J Biol Chem; 2005 May; 280(19):19419-25. PubMed ID: 15760896
[TBL] [Abstract][Full Text] [Related]
10. Relationship between beta-amyloid degradation and the 26S proteasome in neural cells.
Lopez Salon M; Pasquini L; Besio Moreno M; Pasquini JM; Soto E
Exp Neurol; 2003 Apr; 180(2):131-43. PubMed ID: 12684027
[TBL] [Abstract][Full Text] [Related]
11. Induction and attenuation of neuronal apoptosis by proteasome inhibitors in murine cortical cell cultures.
Suh J; Lee YA; Gwag BJ
J Neurochem; 2005 Nov; 95(3):684-94. PubMed ID: 16144541
[TBL] [Abstract][Full Text] [Related]
12. Proteasome inhibitors suppress formation of polyglutamine-induced nuclear inclusions in cultured postmitotic neurons.
Kim WY; Horbinski C; Sigurdson W; Higgins D
J Neurochem; 2004 Dec; 91(5):1044-56. PubMed ID: 15569248
[TBL] [Abstract][Full Text] [Related]
13. Nestin expression is lost in a neural stem cell line through a mechanism involving the proteasome and Notch signalling.
Mellodew K; Suhr R; Uwanogho DA; Reuter I; Lendahl U; Hodges H; Price J
Brain Res Dev Brain Res; 2004 Jul; 151(1-2):13-23. PubMed ID: 15246688
[TBL] [Abstract][Full Text] [Related]
14. Application of proteasomal inhibitors to mouse sympathetic neurons activates the intrinsic apoptotic pathway.
Lang-Rollin I; Vekrellis K; Wang Q; Rideout HJ; Stefanis L
J Neurochem; 2004 Sep; 90(6):1511-20. PubMed ID: 15341534
[TBL] [Abstract][Full Text] [Related]
15. Disruption of the ubiquitin proteasome system following axonal stretch injury accelerates progression to secondary axotomy.
Staal JA; Dickson TC; Chung RS; Vickers JC
J Neurotrauma; 2009 May; 26(5):781-8. PubMed ID: 19416018
[TBL] [Abstract][Full Text] [Related]
16. Rapid turnover of GATA-2 via ubiquitin-proteasome protein degradation pathway.
Minegishi N; Suzuki N; Kawatani Y; Shimizu R; Yamamoto M
Genes Cells; 2005 Jul; 10(7):693-704. PubMed ID: 15966900
[TBL] [Abstract][Full Text] [Related]
17. A therapeutic dose of doxorubicin activates ubiquitin-proteasome system-mediated proteolysis by acting on both the ubiquitination apparatus and proteasome.
Liu J; Zheng H; Tang M; Ryu YC; Wang X
Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2541-50. PubMed ID: 18978187
[TBL] [Abstract][Full Text] [Related]
18. Effect of an experimental proteasome inhibitor on the cytoskeleton, cytosolic protein turnover, and induction in the neuronal cells in vitro.
Csizmadia V; Raczynski A; Csizmadia E; Fedyk ER; Rottman J; Alden CL
Neurotoxicology; 2008 Mar; 29(2):232-43. PubMed ID: 18155769
[TBL] [Abstract][Full Text] [Related]
19. Cbl-mediated ubiquitination of alpha5 integrin subunit mediates fibronectin-dependent osteoblast detachment and apoptosis induced by FGFR2 activation.
Kaabeche K; Guenou H; Bouvard D; Didelot N; Listrat A; Marie PJ
J Cell Sci; 2005 Mar; 118(Pt 6):1223-32. PubMed ID: 15728256
[TBL] [Abstract][Full Text] [Related]
20. The degradation of nascent fibrinogen chains is mediated by the ubiquitin proteasome pathway.
Xia H; Redman C
Biochem Biophys Res Commun; 1999 Aug; 261(3):590-7. PubMed ID: 10441471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
